NeuroBo Pharmaceuticals I... (NRBO)
NASDAQ: NRBO
· Real-Time Price · USD
2.36
null (null%)
At close: Nov 27, 2024, 10:00 PM
NeuroBo Pharmaceuticals Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -1.56 | -1.14 | -6.11 | -1.43 | -0.61 | -0.77 | -0.88 | -1.27 | -6.03 | -2.76 | 4.59 | -7.79 | -7.75 | -16.73 | -11.88 | -47.9 | -37.37 | -57.23 |
PEG Ratio | 0.06 | 0.00 | 0.05 | 0.02 | -0.02 | -0.03 | -0.02 | -0.00 | 0.09 | 0.01 | -0.04 | 1.38 | -0.52 | 0.35 | -0.37 | 3.71 | 0.44 | -55.11 |
PS Ratio | n/a | n/a | 6.32K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 2.59 | 3.82 | 15.94 | 2.50 | 1.30 | 2.05 | 1.13 | 0.90 | 0.70 | 1.40 | 0.84 | 16.39 | 11.59 | 16.13 | 14.90 | 108.27 | 61.84 | 57.86 |
P/FCF Ratio | -8.11 | -3.47 | -23.29 | -5.79 | -3.4 | -3.2 | -5.52 | -6.78 | -8.65 | -11.27 | -10.1 | -41.26 | -37.66 | -39.84 | -75.11 | -264.53 | -163.25 | -123.9 |
P/OCF Ratio | -8.11 | -3.47 | -23.29 | -5.79 | -3.4 | -3.21 | -5.54 | -6.87 | -8.65 | -11.29 | -10.1 | -41.26 | -37.66 | -39.84 | -75.03 | -264.53 | -163.39 | -123.9 |
OCF/S Ratio | n/a | n/a | -271.4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.01 | 0.03 | 0.02 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | n/a | n/a | n/a | n/a | n/a | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 |
Quick Ratio | 2.08 | 1.55 | 1.94 | 2.41 | 2.94 | 2.46 | 3.78 | 5.54 | 7.32 | 2.87 | 2.85 | 4.67 | 8.07 | 8.87 | 7.69 | 4.13 | 8.85 | 14.72 |
Current Ratio | 2.08 | 1.55 | 1.94 | 2.41 | 2.94 | 2.46 | 3.78 | 5.54 | 7.32 | 2.87 | 2.85 | 4.67 | 8.07 | 8.87 | 7.69 | 4.13 | 8.85 | 14.72 |
Asset Turnover | n/a | n/a | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -30 | -1.01 | -344.89 | n/a | n/a | -0.43 | n/a | n/a | n/a |
Return on Equity | -0.42 | -0.84 | -0.65 | -0.44 | -0.53 | -0.67 | -0.32 | -0.18 | -0.03 | -0.13 | 0.05 | -0.53 | -0.37 | -0.24 | -0.31 | -0.57 | -0.41 | -0.25 |
Return on Assets | -0.22 | -0.3 | -0.32 | -0.26 | -0.35 | -0.39 | -0.23 | -0.14 | -0.03 | -0.08 | 0.03 | -0.41 | -0.33 | -0.21 | -0.27 | -0.43 | -0.37 | -0.23 |
Return on Invested Capital | -0.44 | -0.86 | -0.7 | -0.48 | -0.53 | -0.67 | -0.33 | -0.18 | -0.15 | -0.12 | 0.02 | -0.52 | -0.36 | -0.24 | -0.31 | -0.56 | -0.41 | -0.25 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | 0.50 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | -258.65 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | -258.65 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | -279.25 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | -271.4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | -257.44 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |